Related Experiment Video
Updated: Aug 13, 2026

Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo
Published on: July 20, 2019
IFN-dependent down-regulation of the NKG2D ligand H60 on tumors
Jack D Bui1, Leonidas N Carayannopoulos, Lewis L Lanier
1Center for Immunology, Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63310, USA.
Abstract:
In this study, we show that IFN-gamma or IFN-alpha reduce expression of H60 on 3'-methylcholanthrene (MCA) sarcomas from 129/Sv mice. As determined by flow cytometry using either NKG2D tetramers or NKG2D ligand-specific mAb, H60 was identified as the NKG2D ligand most frequently expressed on these sarcomas, and its expression was selectively down-regulated by either IFN-gamma or IFN-alpha in a manner that was dose- and time-dependent and reversible. Down-regulation occurred at the transcript level and was STAT1-dependent. It also had functional consequences. IFN-gamma-treated MCA sarcomas with high levels of H60 were resistant to killing by IL-2-activated NK cells. Resistance was not solely dependent on enhanced MHC class I expression but rather also required H60 down-regulation. IFN-gamma-treated tumor cells also displayed diminished capacity to down-regulate NKG2D on freshly isolated NK cells. Transplanted tumor cells reisolated from immunocompetent mice displayed reduced H60 expression and increased MHC class I expression compared with tumor cells that were either left unmanipulated or reisolated from mice treated with neutralizing IFN-gamma-specific mAb. This report thus represents the first demonstration that certain cytokines and specifically the IFNs regulate expression of specific NKG2D ligands on murine tumors. This process most likely helps to specify the type of immune effector cell populations that participate in host-protective antitumor responses.
Insights
Interferons (IFNs) like IFN-gamma and IFN-alpha down-regulate H60 NKG2D ligand on mouse sarcomas. This impacts natural killer (NK) cell activity and tumor immune evasion.
Area of Science:
- Immunology
- Cancer Biology
- Molecular Biology
Background:
- Natural killer (NK) cell activity is crucial for tumor surveillance.
- NKG2D is a key activating receptor on NK cells, recognizing its ligands on target cells.
- Tumor cells can evade NK cell-mediated killing by modulating NKG2D ligand expression.
Purpose of the Study:
- To investigate the effect of interferons (IFNs) on the expression of NKG2D ligands on 3'-methylcholanthrene (MCA) sarcomas.
- To determine the functional consequences of altered NKG2D ligand expression on anti-tumor immunity.
Main Methods:
- Flow cytometry was used to quantify H60 expression on MCA sarcomas.
- Quantitative real-time PCR was employed to assess transcript levels.
- Experiments involved treatment with IFN-gamma and IFN-alpha, and assessment of NK cell cytotoxicity.
- In vivo studies utilized tumor cell transplantation and analysis of reisolated tumors.
Main Results:
- IFN-gamma and IFN-alpha significantly reduced H60 expression on MCA sarcomas at both protein and transcript levels.
- H60 down-regulation was dose- and time-dependent, reversible, and STAT1-dependent.
- IFN-gamma-induced H60 reduction rendered tumors resistant to IL-2-activated NK cell killing.
- Tumor cells reisolated from immunocompetent mice showed reduced H60 and increased MHC class I expression.
Conclusions:
- This study demonstrates that IFNs regulate NKG2D ligand expression on murine tumors.
- Down-regulation of H60 by IFNs contributes to tumor immune evasion by impairing NK cell recognition and killing.
- These findings highlight a novel mechanism by which cytokines influence anti-tumor immune responses.
More Related Videos
05:24Two Flow Cytometric Approaches of NKG2D Ligand Surface Detection to Distinguish Stem Cells from Bulk Subpopulations in Acute Myeloid Leukemia
Published on: February 21, 2021
06:55Measurement of Natural Killer Cell-Mediated Cytotoxicity and Migration in the Context of Hepatic Tumor Cells
Published on: February 22, 2020
Related Concept Videos
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
The Extrinsic Apoptotic Pathway
The Intrinsic Apoptotic Pathway